Skip to main content
Fig. 1. | Alzheimer's Research & Therapy

Fig. 1.

From: Digital health technologies and Alzheimer’s disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?

Fig. 1.

Trials designs in Alzheimer's disease. A comparison of conventional and DCT designs in AD, with recommendations for optimizing research processes. AD, Alzheimer’s disease; AE, adverse event; APOE, apolipoprotein E; ECG, electrocardiogram; FDG-PET, fluorodeoxyglucose positron emission tomography; MRI, magnetic resonance imaging

Back to article page